Government price cut on insurance drugs shall be restored

Published: 1999-12-30 17:07:00

Updated: 1999-12-30 17:07:00

The KPMA stood a firmly opposing stance against the government special measuring consideration for private clinics, dental clinics and retail pharmacies to ease provisionally obligated reports for their purchasing price lists of insurance drugs, claiming that it not only impaired "the actual purc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK